Reader Response: SARS-CoV-2 Vaccination Safety in Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy. Harth CE. Neurology 2023;101:50-51.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harth CE. Reader Response: SARS-CoV-2 Vaccination Safety in Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy. Neurology 2023;101:50-51.
PMID: 37400257